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 Thymus samples with GC demonstrate unique gene 
expression pattern 
 The differentially expressed transcripts belong to 
pathways involved in immune response, cell signaling, 
cellular movement, cell proliferation and apoptosis. 
These functions are important for GC formation 
 GC B-cell specific RGS13 expression is higher in GC 
positive group and is reciprocally regulated by miRNA 
139-5p and 452-5p 
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BACKGROUND: Myasthenia gravis (MG) is an autoimmune 
neuromuscular disorder resulting in weakness of voluntary 
muscles. It is caused by antibodies directed against proteins 
present at the post-synaptic surface of neuromuscular junction. 
A characteristic pathology of patients with early onset MG is 
thymic  hyperplasia with ectopic germinal centers (GC). 
However, mechanisms that trigger and maintain thymic 
hyperplasia are poorly characterized.  
 
OBJECTIVE: We assessed the differential mRNA expression 
profiles in MG thymus samples with and without GC. We 
evaluated pathways involved in GC maintenance. We studied 
expression and regulation of GC specific transcript RGS13. 
 
Fig.1 Germinal center activity in MG thymus 
Adapted from B. A. Heesters et. al., 2014,  Nature Reviews Immunology 
METHODS: Thymic specimens collected during the course of 
the NIH-supported study of thymectomy (MGTX, U01 NS4268) 
were used for histological analysis and grouped based on 
presence (GC positive) or absence of GC (GC negative). 
Transcription profiling was done using GeneChip® Human 
Transcriptome Array 2.0. Partek Genomic Suite 6.6 and 
Transcriptome Analysis Console 2.0 programs were used to 
identify candidates that were differentially expressed. ANOVA p-
value <0.05 and FDR<0.05 was determined as significant. 
Further validation by qRT-PCR was done. IHC was performed 
to study localization of selected proteins.  
Gene ontology (GO) enrichment analysis and Ingenuity 
Pathway Analysis (IPA) core analysis was used to identify 
pathways, molecular and cellular functions of the transcripts 
with respect to GC formation.  
Fig.2 Distinct mRNA expression pattern in MG thymus  
samples with ectopic GC  
 
Differential mRNA expression profiles of thymus samples with and without 
germinal centers. (A) Principal Component Analysis plot (Blue GC positive, Red 
GC negative) and (B) Hierarchical clustergram (ANOVA p<0.05, no fold change). 
GC positive n=7; GC negative n=6.  
Fig.3  Differentially expressed genes belong to functional 
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Fig.4 RGS13 is overexpressed in ectopic GC  
A B C 
(A) Increase in RGS13 expression as determined by qRT-PCR is 
associated with decrease in (B) miR 139-5p and (C) miR 452-5p in GC 
positive samples. (D) Immunohistochemistry of thymus samples using 
RGS13 antibody confirms its expression in GC.  
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(A) 3’UTR of RGS13 gene has predicted binding sites for miR-139-5p 
and miR-452-5p. (B) qRT-PCR analysis RGS13 expression in Raji cells 
post transfection with miRNA mimics. p<0.05 is considered as 
significant.  
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